To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

Clinical trial NCT07208591 · RECRUITING

Trial details

NCT number: NCT07208591
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome (ARDS)

Start date: 2025-10-31
Primary completion: 2026-07-01
Enrollment: 406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.